Economic Times
Ø Govt mulls tax sops on Esops, VC investments
Ø 'Energy sector will generate $250 bn investment'
Ø June 30 deadline for exchanging of pre-2005 notes
Ø Govt delays bankruptcy law, GST deadlock remains
Ø Govt says closing in on Westinghouse deal worth $150 bn to build 6 nuclear reactors
Ø OVL's $1.26 bn Vankor buy to be signed tomorrow
Ø Essar Oil gets okay for institutional sell-off; time to delist from bourses
Business Standard
Ø Draft rules tighten tax norms for MNCs
Ø Sebi panel advises on removing 'conflict of interest' while rating
Ø Rajan raises concerns over high corporate sector vulnerabilities
Ø RCom suspends launch of Free Basics till TRAI's approval
Ø World Bank feelers to part-finance India Post's payments bank
Ø Indian Railways signs Rs 500 cr pact with Coal India for supply of 2,000 wagons
Business Line
Ø Bankruptcy code referred to Joint Select Committee of Parliament
Ø CBDT issues MAT order pertains to foreign companies
Ø Piramal Enterprises buys 5 OTC brands for Rs 92 crore
Ø Court asks MCA to decide on FTIL-NSEL merger by Feb 15
Ø Lupin gets USFDA nod to market potassium chloride capsules
Ø Nalco inks R&D pact with Chalieco of China
Mint
Ø Idea launches 4G services in five southern states
Ø Weak corporate balance sheets need monitoring: RBI report
Ø Small investors in dark over Sahara's latest shadow banking schemes
Ø Welspun Enterprises divests 37% stake in Dewas Bhopal road project
Ø Boards raise scrutiny as Infosys and Wipro bet big on start-ups
Financial Express
Ø Sensex rebounds 259.65 points, Nifty ends at 7,866
Ø DLF gets Rs 1992 cr from GIC from stake sale in 2 projects
Ø NPAs jump 50 bps to 5.1% between March and September quarters: RBI
Ø Dr Lal, Alkem make strong debut on bourses
Ø SAIL to soon launch Rs 400-crore voluntary retirement scheme
Financial Chronicle
Ø Wipro to acquire Viteos Group for $130m in outsourcing push
Ø L&T bags orders worth Rs 1,178 crore in December
Ø Over Rs 16k cr undisclosed income detected in 20 months
Ø Sebi attachment orders up 5-fold at 1,610 in FY15
Ø M&As peak in pharma industry; so does regulatory glare
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.
No comments:
Post a Comment